Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00003397
Ignite Creation Date: 2024-05-05 @ 10:05 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003397
Protocol Section: NCT00003397
Start Identification Module Data
Expand Identification Module Data
Brief Title: Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkins Lymphoma
Official Title: Autologous Stem Cell Transplantation for Poor Prognosis Relapsed or Refractory Intermediate-High Grade B-Cell Lymphoma Using Gemcitabine Plus High Dose BCNU and Melphalan Followed by Anti-CD20 Moab IDEC C2B8 Rituximab Rituxan and Consolidative Chemotherapy
Acronym: None
Organization: University of Maryland Baltimore
Organization Class: OTHER
Organization Study ID: CDR0000066399
Secondary IDs
Secondary ID Type Domain Link
NCI-V98-1432 None None None
MSGCC-9740 None None None
Start Status Module Data
Status Verified Date: 2019-10
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: University of Maryland Baltimore
Lead Sponsor Class: OTHER
Lead Sponsor: University of Maryland Baltimore
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload